Kairos Pharma Ltd. (NYSE KAPA) Revenue and Competitors
Estimated Revenue & Valuation
- Kairos Pharma Ltd. (NYSE KAPA)'s estimated annual revenue is currently $155k per year.
- Kairos Pharma Ltd. (NYSE KAPA)'s estimated revenue per employee is $155,000
Employee Data
- Kairos Pharma Ltd. (NYSE KAPA) has 1 Employees.
- Kairos Pharma Ltd. (NYSE KAPA) grew their employee count by 0% last year.
Kairos Pharma Ltd. (NYSE KAPA)'s People
| Name | Title | Email/Phone |
|---|
Kairos Pharma Ltd. (NYSE KAPA) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Kairos Pharma Ltd. (NYSE KAPA)?
Kairos Pharma is focused on developing cutting-edge therapeutics for cancer patients that reverse the inhibitory effects of cancer on the immune system. By doing so, we seek to transform the way cancer is treated by positively impacting patient outcomes while maintaining quality of life.
keywords:N/A
N/A
Total Funding
1
Number of Employees
$155k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Los Angeles
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 1 | -83% | N/A |
#2 | $0M | 1 | 0% | $6.9M |
#3 | $0M | 1 | 0% | $120.7M |
#4 | $0.1M | 1 | 0% | N/A |
#5 | $0.1M | 1 | -50% | N/A |